Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA issues documents on advisory committee financial conflicts and scientific integrity. More regulatory updates.

You may also be interested in...

Manufacturers Share Doubts About FDA’s ISO 13485 Audit Report Program

A voluntary new FDA program aims to relieve the inspectional load on manufacturers and the agency. But some device companies are skeptical that anyone will participate.

FDA Develops Scientific Integrity Guide For Staff

FDA plans to publicly issue its staff manual on scientific integrity in the near future.

Draft Guidance: Clean ISO Audit Report May Permit Delayed FDA Inspections

Device companies may be able to put off an FDA facility inspection if the plant has recently satisfied international quality system standards, according to a 1draft guidance released by the agency May 20

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts